Bausch + Lomb Names Charl van Zyl as Commercial Leader, Europe, Middle East and Africa

Bausch + Lomb Names Charl van Zyl as Commercial Leader, Europe, Middle East and Africa

ROCHESTER, N.Y. -- Bausch + Lomb, the global eye health company, has named Charl van Zyl as corporate vice president and commercial leader, Europe, Middle East and Africa (EMEA).

 

"Charl is a strong, strategic leader with a proven ability to drive executional excellence," said Brent Saunders, chief executive officer, Bausch + Lomb. "In this newly created role, Charl will be placing a special focus on building high-performance, customer-centric teams for our Vision Care, Pharmaceuticals and Surgical businesses in all our markets across this important region."

Mr. van Zyl will lead the company's cross-functional, multi-market EMEA operations team. He will also have direct commercial responsibility for B+L's emerging markets in the region.

Mr. van Zyl joined Bausch + Lomb in 2009, serving as vice president, EMEA, for the company's Pharmaceuticals business. In recent months he has taken on additional region-wide responsibilities.

Before coming to B+L, Mr. van Zyl was chief executive officer for Jado Technologies, the German biotechnology firm. From 2004 to 2007 he held positions at Novartis Pharma AG as head of Marketing and Sales, Pharma Europe, and head of Global Marketing, Ophthalmics. Earlier in his career he held multiple positions with Eli Lilly & Co, with responsibilities spanning across Japan, the United States, Europe and Latin America.

Mr. van Zyl graduated from the University of Cape Town with Bachelors of Science (Medicine) Honours and MBA degrees. He will be based at Bausch + Lomb's offices in Zug, Switzerland.

# # #

News Media Contact:

Mike McDougall Vice President, Corporate Communications and Public Affairs +1-585-338-5469 or [email protected]

About Bausch + Lomb Bausch + Lomb is dedicated to bringing visionary ideas to eye health. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. The Bausch + Lomb name is one of the best-known and most respected health care brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com<http://%20www.bausch.com/>.

 

 

Suggested Articles

Denali is partnering with Biogen on its Parkinson's disease program, netting a $560 million upfront fee and a $465 million investment.

In the first half of 2020, the regenerative medicine sector raised $10.7 billion, more than the total it raised in 2019.

The trial linked RG6346 to reductions in hepatitis B surface antigen that suggest the RNAi therapy can hold its own against drugs from J&J and Vir.